Recent Patents on Cardiovascular Drug Discovery

Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase
pp. 129-139(11)
Authors: Nangaku, Nangaku; Kojima, Ichiro; Tanaka, Tetsuhiro; Ohse, Takamoto; Kato, Hideki; Fujita, Fujita

Potential Applications of RNA Interference-Based Therapeutics in the Treatment of Cardiovascular Disease
pp. 141-149(9)
Author: Hassan, Ali

Oxidative Stress in Cardiovascular Disease: A New Avenue Toward Future Therapeutic Approaches
pp. 151-159(9)
Author: Inagi, Reiko

99mTc-N-DBODC5: A Novel Myocardial Perfusion Imaging Agent for Diagnosis of Coronary Artery Disease, a Review
pp. 161-166(6)
Authors: Takeda, Tohoru; Wu, Jin; Thet-Thet-Lwin,

Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
pp. 167-175(9)
Authors: Khan, Zia A.; Chakrabarti, Subrata

Vasopressin Receptor Antagonists in Heart Failure
pp. 177-184(8)
Authors: Hobbs, Robert E.; Wilson Tang, W. H.

Levosimendan: A Novel Agent in Heart Failure
pp. 185-191(7)
Authors: Koumallos, Nikolas; Antoniades, Charalambos; Tousoulis, Dimitris; Shirodaria, Cheerag; Stefanadis, Christodoulos

Role of PPAR in Cardiovascular Diseases
pp. 193-209(17)
Authors: Das, Saibal K.; Chakrabarti, Ranjan

Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs
pp. 211-224(14)
Authors: Chen, Gregory J.; Forough, Reza

Patent Annotations
pp. 225-227(3)

Patent Selections
pp. 229-231(3)